Internal Medicine - Issue 9/2017
Original Contributions
548
Thyroid disease in the Czech Republic: the EUthyroid project and the evaluation of the General Health Insurance Company epidemiological data for the period of 2012–2015
Radovan Bílek, Lenka Horáková, Robert Goš, Václav Zamrazil
555
Thyroid screening in pregnancy – guideline in practice
Patrícia Páleníková, Iveta Kalafutová, Zdenka Horníková, Juraj Payer
Reviews
561
Valvular heart disease in relation to the treatment of hyperprolactinemia with dopamine agonists
Filip Gabalec, Jan Čáp, Jakub Radocha
566
572
Thyroid carcinomas: the present view on diagnostics and therapy
Petr Vlček, Dana Nováková, Rami Katra
580
Diagnosis and management of metastatic pheochromocytoma and paraganglioma
Ivana Jochmanová, Ivica Lazúrová
589
Bone quality in patients with acromegaly
Martin Kužma, Ivana Ságová, Dušan Pávai, Peter Jackuliak, Zdenko Killinger, Peter Vaňuga, Juraj Payer
593
598
Anabolic steroid induced hypogonadism in men: overview and case report
Luboslav Stárka, Michaela Dušková, Lucie Kolátorová, Oldřich Lapčík
604
Primary hyperparathyroidism – new clinical forms of the disease
Kateřina Zajíčková
609
Antidiabetic drugs and their effect on bone
Peter Jackuliak, Martin Kužma, Juraj Payer
617
Adenosine – a mediator with multisystemic effects (or a hormone?)
Zora Lazúrová, Peter Mitro
Internal Medicine
2017 Issue 9
Most read in this issue
- Adenosine – a mediator with multisystemic effects (or a hormone?)
- Anabolic steroid induced hypogonadism in men: overview and case report
- Thyroid carcinomas: the present view on diagnostics and therapy
- Primary hyperparathyroidism – new clinical forms of the disease